• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4643608)   Today's Articles (34)   Subscriber (50572)
For: Drexler HG, Matsuo Y. Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia. Leuk Res 2000;24:681-703. [PMID: 10936422 DOI: 10.1016/s0145-2126(99)00195-2] [Citation(s) in RCA: 81] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Number Cited by Other Article(s)
51
Lombardi L, Poretti G, Mattioli M, Fabris S, Agnelli L, Bicciato S, Kwee I, Rinaldi A, Ronchetti D, Verdelli D, Lambertenghi-Deliliers G, Bertoni F, Neri A. Molecular characterization of human multiple myeloma cell lines by integrative genomics: Insights into the biology of the disease. Genes Chromosomes Cancer 2007;46:226-38. [PMID: 17171682 DOI: 10.1002/gcc.20404] [Citation(s) in RCA: 56] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]  Open
52
Obeng EA, Carlson LM, Gutman DM, Harrington WJ, Lee KP, Boise LH. Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood 2006;107:4907-16. [PMID: 16507771 PMCID: PMC1895817 DOI: 10.1182/blood-2005-08-3531] [Citation(s) in RCA: 883] [Impact Index Per Article: 49.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2005] [Accepted: 02/13/2006] [Indexed: 02/07/2023]  Open
53
Taylor BJ, Reiman T, Pittman JA, Keats JJ, de Bruijn DRH, Mant MJ, Belch AR, Pilarski LM. SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCs. J Immunother 2006;28:564-75. [PMID: 16224274 DOI: 10.1097/01.cji.0000175685.36239.e5] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
54
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood 2006. [PMID: 16507771 DOI: 10.1182/blood-2005-08-3531;] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]  Open
55
Tinhofer I, Biedermann R, Krismer M, Crazzolara R, Greil R. A role of TRAIL in killing osteoblasts by myeloma cells. FASEB J 2006;20:759-61. [PMID: 16436464 DOI: 10.1096/fj.05-4329fje] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
56
Lin B, Catley L, LeBlanc R, Mitsiades C, Burger R, Tai YT, Podar K, Wartmann M, Chauhan D, Griffin JD, Anderson KC. Patupilone (epothilone B) inhibits growth and survival of multiple myeloma cells in vitro and in vivo. Blood 2005;105:350-7. [PMID: 15367426 DOI: 10.1182/blood-2004-06-2499] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
57
Caers J, Asosingh K, Van Riet I, Van Camp B, Vanderkerken K. Of mice and men: disease models of multiple myeloma. ACTA ACUST UNITED AC 2004. [DOI: 10.1016/j.ddmod.2004.11.010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
58
Matsuo Y, Drexler HG, Harashima A, Okochi A, Hasegawa A, Kojima K, Orita K. Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing δ/λ type immunoglobulin. Leuk Res 2004;28:869-77. [PMID: 15203285 DOI: 10.1016/j.leukres.2003.12.008] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2003] [Accepted: 12/12/2003] [Indexed: 10/26/2022]
59
Magrangeas F, Cormier ML, Descamps G, Gouy N, Lodé L, Mellerin MP, Harousseau JL, Bataille R, Minvielle S, Avet-Loiseau H. Light-chain only multiple myeloma is due to the absence of functional (productive) rearrangement of the IgH gene at the DNA level. Blood 2004;103:3869-75. [PMID: 14715636 DOI: 10.1182/blood-2003-07-2501] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
60
Donner LR. Epstein-Barr Virus-induced Transformation of Cutaneous Plasmacytoma into CD30+ Diffuse Large B-cell Lymphoma. Am J Dermatopathol 2004;26:63-6. [PMID: 14726824 DOI: 10.1097/00000372-200402000-00009] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
61
Drexler HG, Matsuo Y, MacLeod RAE. Persistent Use of False Myeloma Cell Lines. Hum Cell 2003;16:101-5. [PMID: 15005240 DOI: 10.1111/j.1749-0774.2003.tb00140.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
62
Ohbayashi K, Taniwaki M, Ninomiya M, Kiyoi H, Iida S, Ueda R, Naoe T. A xeno-transplantable plasma cell leukemia line with a split translocation of the IgH gene. CANCER GENETICS AND CYTOGENETICS 2003;144:31-5. [PMID: 12810253 DOI: 10.1016/s0165-4608(02)00862-2] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
63
Firer MA, Laptev R, Kasatkin I, Trombka D. Specific destruction of hybridoma cells by antigen-toxin conjugates demonstrate an efficient strategy for targeted drug therapy in leukemias of the B cell lineage. Leuk Lymphoma 2003;44:681-9. [PMID: 12769346 DOI: 10.1080/1042819031000063381] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
64
Drexler HG, Dirks WG, Matsuo Y, MacLeod RAF. False leukemia-lymphoma cell lines: an update on over 500 cell lines. Leukemia 2003;17:416-26. [PMID: 12592342 DOI: 10.1038/sj.leu.2402799] [Citation(s) in RCA: 145] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2002] [Accepted: 10/01/2002] [Indexed: 11/09/2022]
65
Drexler HG, MacLeod RAF. Leukemia-lymphoma cell lines as model systems for hematopoietic research. Ann Med 2003;35:404-12. [PMID: 14572164 DOI: 10.1080/07853890310012094] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]  Open
66
Drexler HG, MacLeod RAF. Malignant hematopoietic cell lines: in vitro models for the study of mantle cell lymphoma. Leuk Res 2002;26:781-7. [PMID: 12127550 DOI: 10.1016/s0145-2126(02)00026-7] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
67
Lai R, McDonnell TJ, O'Connor SL, Medeiros LJ, Oudat R, Keating M, Morgan MB, Curiel TJ, Ford RJ. Establishment and characterization of a new mantle cell lymphoma cell line, Mino. Leuk Res 2002;26:849-55. [PMID: 12127561 DOI: 10.1016/s0145-2126(02)00013-9] [Citation(s) in RCA: 40] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
68
Drexler HG, Uphoff CC, Dirks WG, MacLeod RAF. Mix-ups and mycoplasma: the enemies within. Leuk Res 2002;26:329-33. [PMID: 11839374 DOI: 10.1016/s0145-2126(01)00136-9] [Citation(s) in RCA: 48] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
69
Avet-Loiseau H, Facon T, Grosbois B, Magrangeas F, Rapp MJ, Harousseau JL, Minvielle S, Bataille R. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation. Blood 2002;99:2185-91. [PMID: 11877296 DOI: 10.1182/blood.v99.6.2185] [Citation(s) in RCA: 264] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
70
Kuehl WM, Bergsagel PL. Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer 2002;2:175-87. [PMID: 11990854 DOI: 10.1038/nrc746] [Citation(s) in RCA: 592] [Impact Index Per Article: 26.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
71
Drexler HG, Matsuo Y. Commentary: what is an 'NK-precursor cell line'? Leuk Res 2002;26:297-9. [PMID: 11792419 DOI: 10.1016/s0145-2126(01)00116-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
72
Ueda C, Yamada H, Akasaka T, Ohmori K, Sasada M, Uchiyama T, Ohno H. Establishment and characterization of a new human myeloma cell line, KYdelta-1, producing the delta/kappa type immunoglobulin. CANCER GENETICS AND CYTOGENETICS 2001;130:42-50. [PMID: 11672773 DOI: 10.1016/s0165-4608(01)00467-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
73
Otsuki T, Wada H, Nakazawa N, Taniwaki M, Kouguchi K, Ohkura M, Uehira K, Isoda K, Yata K, Sakaguchi H, Yawata Y, Ueki A, Yamada O. Establishment of CD7+ human myeloma sister cell lines, KMS-21-PE and KMS-21-BM, carrying t(11;14) and t(8;14). Leuk Lymphoma 2001;42:761-74. [PMID: 11697507 DOI: 10.3109/10428190109099339] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
74
Shapiro VS, Mollenauer MN, Weiss A. Endogenous CD28 expressed on myeloma cells up-regulates interleukin-8 production: implications for multiple myeloma progression. Blood 2001;98:187-93. [PMID: 11418479 DOI: 10.1182/blood.v98.1.187] [Citation(s) in RCA: 43] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
75
Drexler HG, Matsuo AY, MacLeod RA. Continuous hematopoietic cell lines as model systems for leukemia-lymphoma research. Leuk Res 2000;24:881-911. [PMID: 11086173 DOI: 10.1016/s0145-2126(00)00070-9] [Citation(s) in RCA: 71] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
PrevPage 2 of 2 12Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA